These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 24684842)
1. Design, synthesis, and biological evaluation of dihydroartemisinin-fluoroquinolone conjugates as a novel type of potential antitubercular agents. Zhou FW; Lei HS; Fan L; Jiang L; Liu J; Peng XM; Xu XR; Chen L; Zhou CH; Zou YY; Liu CP; He ZQ; Yang DC Bioorg Med Chem Lett; 2014 Apr; 24(8):1912-7. PubMed ID: 24684842 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, biological evaluation, structure-activity relationship, and toxicity of clinafloxacin-azole conjugates as novel antitubercular agents. Liu J; Ren Z; Fan L; Wei J; Tang X; Xu X; Yang D Bioorg Med Chem; 2019 Jan; 27(1):175-187. PubMed ID: 30522898 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitubercular evaluation of new fluoroquinolone derivatives coupled with carbohydrates. Saraiva MF; de Souza MV; Tran Huu Dau ME; Araújo DP; de Carvalho GS; de Almeida MV Carbohydr Res; 2010 Apr; 345(6):761-7. PubMed ID: 20167309 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis. Gomez C; Ponien P; Serradji N; Lamouri A; Pantel A; Capton E; Jarlier V; Anquetin G; Aubry A Bioorg Med Chem; 2013 Feb; 21(4):948-56. PubMed ID: 23294829 [TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin and its Analogs: A New Class of Antitubercular Agents. Kalani K; Chaturvedi V; Trivedi P; Tondon S; Srivastava SK Curr Top Med Chem; 2019; 19(8):594-599. PubMed ID: 30836916 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitubercular activity of palladium and platinum complexes with fluoroquinolones. Vieira LM; de Almeida MV; Lourenço MC; Bezerra FA; Fontes AP Eur J Med Chem; 2009 Oct; 44(10):4107-11. PubMed ID: 19482387 [TBL] [Abstract][Full Text] [Related]
8. In Vitro, In Silico and Ex Vivo Studies of Dihydroartemisinin Derivatives as Antitubercular Agents. Kalani K; Alam S; Chaturvedi V; Singh S; Khan F; Srivastava SK Curr Top Med Chem; 2019; 19(8):633-644. PubMed ID: 30834834 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitubercular activity of lipophilic moxifloxacin and gatifloxacin derivatives. de Almeida MV; Saraiva MF; de Souza MV; da Costa CF; Vicente FR; Lourenço MC Bioorg Med Chem Lett; 2007 Oct; 17(20):5661-4. PubMed ID: 17804222 [TBL] [Abstract][Full Text] [Related]
10. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase. Sriram D; Aubry A; Yogeeswari P; Fisher LM Bioorg Med Chem Lett; 2006 Jun; 16(11):2982-5. PubMed ID: 16554151 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents. Lokesh BVS; Prasad YR; Shaik AB Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506 [TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone derivatives and their anti-tubercular activities. Fan YL; Wu JB; Cheng XW; Zhang FZ; Feng LS Eur J Med Chem; 2018 Feb; 146():554-563. PubMed ID: 29407980 [TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Pharmacological Evaluation of Some C Niveditha N; Begum M; Prathibha D; Sirisha K; Mahender P; Chitra C; Rao VR; Reddy VM; Achaiah G Chem Pharm Bull (Tokyo); 2020; 68(12):1170-1177. PubMed ID: 33268649 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids. Xu Z; Zhang S; Song X; Qiang M; Lv Z Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 2-aminothiazole-thiazolidinone conjugates as potential antitubercular agents. Abo-Ashour MF; Eldehna WM; George RF; Abdel-Aziz MM; Elaasser MM; Abou-Seri SM; Abdel Gawad NM Future Med Chem; 2018 Jun; 10(12):1405-1419. PubMed ID: 29788758 [TBL] [Abstract][Full Text] [Related]
17. Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: Design, synthesis and in vitro anti-mycobacterial evaluation. Xu Z; Song XF; Hu YQ; Qiang M; Lv ZS Eur J Med Chem; 2017 Sep; 138():66-71. PubMed ID: 28646656 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
19. New fluoroquinolones active against fluoroquinolones-resistant Mycobacterium tuberculosis strains. Guerrini V; De Rosa M; Pasquini S; Mugnaini C; Brizzi A; Cuppone AM; Pozzi G; Corelli F Tuberculosis (Edinb); 2013 Jul; 93(4):405-11. PubMed ID: 23523640 [TBL] [Abstract][Full Text] [Related]
20. Novel fluoroquinolones: design, synthesis, and in vivo activity in mice against Mycobacterium tuberculosis H37Rv. Shindikar AV; Viswanathan CL Bioorg Med Chem Lett; 2005 Apr; 15(7):1803-6. PubMed ID: 15780610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]